Dr Salman Razvi
| Editorial: Treatment of Subclinical Thyroid Dysfunction in Patients with Comorbidities | 2023 |
|
Dr Petros Perros
Professor Simon Pearce
Dr Salman Razvi
Dr Alison Dickinson
| Inter-observer Variability of Clinical Activity Score: Assessments in Patients With Thyroid Eye Disease | 2023 |
|
Sophie Howarth
Kathleen Allinson
Dr Salman Razvi
Dr Anna Mitchell
Professor Simon Pearce
et al. | Replication of association at the LPP and UBASH3A loci in a UK autoimmune Addison's disease cohort. | 2023 |
|
Dr Salman Razvi
| Subclinical hypothyroidism, outcomes and management guidelines: a narrative review and update of recent literature. | 2023 |
|
Dr Salman Razvi
| The GLP-1 receptor agonist Exenatide reduces serum TSH by its effect on body weight in people with Type 2 Diabetes | 2023 |
|
Dr Salman Razvi
Dr Avais Jabbar
Clare Addison
| Variation in the reference range limits of thyroid function tests and association with the prevalence of levothyroxine treatment | 2023 |
|
Emily Hunter
Professor Anthony De Soyza
Dr Rachel Agbeko
Dr Ken Baker
Dr Quentin Campbell Hewson
et al. | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial | 2022 |
|
Dr Ryan Kenny
Professor John Dark
Dr Arjola Bano
Dr Salman Razvi
| Efficacy and safety of Triiodothyronine (T3) treatment in Cardiac Surgery or Cardiovascular Diseases – a Systematic Review and Meta-analysis of Randomized Controlled Trials | 2022 |
|
Dr David Kennedy
Dr Salman Razvi
| Frequency, Determinants and Costs of Thyroid Function Testing in a Laboratory serving a large Population | 2022 |
|
Dr Salman Razvi
| Getting the levothyroxine (LT4) dose right for adults with hypothyroidism: opportunities and challenges in the use of modern LT4 preparations | 2022 |
|
Dr Salman Razvi
| Hypothyroidism | 2022 |
|
Dr Petros Perros
Dr Bijayeswar Vaidya
Dr John Lazarus
Dr Salman Razvi
Dr Asgar Madathil
et al. | Post-radioiodine Graves' management: the PRAGMA study | 2022 |
|
Dr Salman Razvi
| Subclinical thyroid dysfunction and incident diabetes: a systematic review and an individual participant data analysis of prospective cohort studies. | 2022 |
|
Nicholas Vennart
Dr Jolanta Weaver
Dr Salman Razvi
| The prevalence and significance of non-uniform thyroid radio-isotope uptake in patients with Graves’ disease | 2022 |
|
Dr Salman Razvi
Dr Avais Jabbar
Professor Azfar Zaman
| Triiodothyronine (T3), inflammation and mortality risk in patients with acute myocardial infarction | 2022 |
|
Shaun Hiu
Professor Dawn Teare
Dr Salman Razvi
| A Global Country Level Analysis of The Relationship between Obesity and COVID-19 Cases and Mortality | 2021 |
|
Dr Salman Razvi
| Association of diabetes with atrial fibrillation types: a systematic review and meta-analysis | 2021 |
|
Dr Salman Razvi
| Does Clinical and Biochemical Thyroid Dysfunction Impact on Endometrial Cancer Survival Outcomes? A Prospective Database Study | 2021 |
|
Dr Kerri Devine
Dr Salman Razvi
Dr Richard Quinton
Dr Nicola Leech
| Iatrogenic hypoglycaemia following glucose-insulin infusions for the treatment of hyperkalaemia | 2021 |
|
Dr Salman Razvi
Dr Bronia Arnott
Shaun Hiu
Dr Nicki O'Brien
Professor Simon Pearce
et al. | Multinational Survey of Treatment Practices of Clinicians Managing Subclinical Hypothyroidism in Older People in 2019 | 2021 |
|
Dr Avais Jabbar
Lorna Ingoe
Dr Shahid Junejo
Dr David Austin
Professor Azfar Zaman
et al. | Prevalence, Predictors and Outcomes of Thyroid Dysfunction in patients with Acute Myocardial Infarction: the ThyrAMI-1 Study | 2021 |
|
Dr Salman Razvi
| Treatment of subclinical hypothyroidism: assessing when treatment is likely to be beneficial | 2021 |
|
Dr Salman Razvi
Vicky Ryan
Professor Simon Pearce
Dr Scott Wilkes
| Age-related serum Thyroid Stimulating Hormone Reference range in Older Patients treated with Levothyroxine: a Randomized Controlled Feasibility Trial (SORTED 1) | 2020 |
|
Dr Avais Jabbar
Lorna Ingoe
Dr Shahid Junejo
Dr Peter Carey
Dr Honey Thomas
et al. | Effect of levothyroxine on left ventricular ejection fraction in patients with subclinical hypothyroidism and acute myocardial infarction: a randomized clinical trial | 2020 |
|
Dr Salman Razvi
| Exposure of hospital healthcare workers to the novel coronavirus (SARS-CoV-2) | 2020 |
|
Dr Salman Razvi
| Managing symptoms in hypothyroid patients on adequate levothyroxine: a narrative review | 2020 |
|
Dr Salman Razvi
Dr Akheel Syed
| Obesity: A critical risk factor in the COVID‐19 pandemic | 2020 |
|
Dr Salman Razvi
Dr Avais Jabbar
Dr Arjola Bano
Lorna Ingoe
Dr Peter Carey
et al. | Sample Timing, Diagnosis of Subclinical Thyroid Dysfunction and Mortality in Acute Myocardial Infarction: ThyrAMI1 Study | 2020 |
|
Dr Salman Razvi
| Thyroid function and the risk of fibrosis of the liver, heart and lung in humans: A systematic review and meta-analysis | 2020 |
|
Professor Simon Pearce
Dr Petros Perros
Dr Salman Razvi
| Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study | 2019 |
|
Dr Salman Razvi
| Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction | 2019 |
|
Dr Salman Razvi
| Hypothyroidism in the older population | 2019 |
|
Dr Salman Razvi
| Liothyronine cost and prescriptions in England | 2019 |
|
Dr Salman Razvi
| Novel uses of thyroid hormones in cardiovascular conditions | 2019 |
|
Dr Salman Razvi
| Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers | 2019 |
|
Dr Salman Razvi
| Therapeutic challenges in the application of serum thyroid stimulating hormone testing in the management of patients with hypothyroidism on replacement thyroid hormone therapy: a review | 2019 |
|
Dr Salman Razvi
Professor Simon Pearce
| Thyroid Hormone Therapy for Subclinical Hypothyroidism [Comment & Response] | 2019 |
|
Dr Arjola Bano
Dr Earn Gan
Dr Jolanta Weaver
Dr Salman Razvi
| Age may influence the impact of TRAbs on thyroid function and relapse-risk in patients with Graves’ disease | 2018 |
|
Dr Laura Lane
Kathleen Allinson
Lorna Ingoe
Dr Salman Razvi
Professor Timothy Cheetham
et al. | Analysis of BAFF gene polymorphisms in UK Graves' disease patients | 2018 |
|
Professor Simon Pearce
Dr Salman Razvi
| Attitudes and perceptions of health professionals towards management of hypothyroidism in general practice: a qualitative interview study. | 2018 |
|
Lorna Ingoe
Professor Simon Pearce
Professor Tim Rapley
Dr Salman Razvi
Dr Scott Wilkes
et al. | Older patients' experience of primary hypothyroidism: A qualitative study | 2018 |
|
Dr Salman Razvi
Dr Avais Jabbar
Professor Azfar Zaman
| Thyroid Hormones and Cardiovascular Function and Diseases | 2018 |
|
Dr Salman Razvi
| Trends, Determinants and Associations of Treated Hypothyroidism in the United Kingdom, 2005-2014 | 2018 |
|
Dr Salman Razvi
Professor Simon Pearce
Dr Scott Wilkes
| Clinical, behavioural and pharmacogenomic factors influencing the response to levothyroxine therapy in patients with primary hypothyroidism-protocol for a systematic review | 2017 |
|
Professor Simon Pearce
Dr Salman Razvi
Dr Scott Wilkes
| Patients' attitudes and perceptions towards treatment of hypothyroidism in general practice: an in-depth qualitative interview study | 2017 |
|
Lorna Ingoe
Arvind Rajagopal
Dr Salman Razvi
| Prevalence of treated hypothyroidism in the community: Analysis from general practices in North-East England with implications for the United Kingdom | 2017 |
|
Dr Earn Gan
Dr Salman Razvi
| The role of local thyroid hormone perturbation in hippocampal sclerosis dementia - commentary on a multi-modality study | 2017 |
|
Dr Avais Jabbar
Professor Simon Pearce
Professor Azfar Zaman
Dr Salman Razvi
| Thyroid hormones and cardiovascular disease | 2017 |
|
Dr Salman Razvi
Lorna Ingoe
Vicky Ryan
Professor Simon Pearce
Dr Scott Wilkes
et al. | Study of Optimal Replacement of Thyroxine in the Elderly (SORTED) - results from the feasibility randomised controlled trial | 2016 |
|
Dr Avais Jabbar
Dr Salman Razvi
| Thyroid disease and vascular risk | 2014 |
|
Dr Salman Razvi
Professor Simon Pearce
| Subclinical Hypothyroidism and Cardiovascular Disease Reply | 2012 |
|
Dr Salman Razvi
Dr Jolanta Weaver
| Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: The ThyDQoL and ThySRQ | 2008 |
|
Dr Salman Razvi
Dr Jolanta Weaver
Professor Simon Pearce
| The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: A metaanalysis | 2008 |
|
Dr Salman Razvi
Professor Simon Pearce
| Do antithyroid drugs influence outcome after radioiodine therapy for hyperthyroidism? | 2007 |
|
Dr Salman Razvi
Lorna Ingoe
Crispian Oates
Dr Jolanta Weaver
| The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: Randomized, crossover trial | 2007 |
|
Dr Salman Razvi
Dr Jolanta Weaver
| Psychometric evaluation of a new questionnaire measuring treatment satisfaction in hypothyroidism: The ThyTSQ | 2006 |
|
Dr Salman Razvi
Dr Bijayeswar Vaidya
Dr Petros Perros
Professor Simon Pearce
| What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves' disease | 2006 |
|
Dr Jolanta Weaver
Dr Salman Razvi
| Dose of anti-thyroid drugs can effect remission in grave's disease | 2005 |
|
Dr Salman Razvi
Lorna Ingoe
Dr Jolanta Weaver
| Health status in patients with sub-clinical hypothyroidism | 2005 |
|
Dr Salman Razvi
Dr Jolanta Weaver
| Instruments used in measuring symptoms, health status and quality of life in hypothyroidism: A systematic qualitative review | 2005 |
|
Dr Salman Razvi
Dr Elizabeth McIntyre
Dr S Wahid
Dr Jolanta Weaver
| Low failure rate of fixed administered activity of 400 MBq 131I with pre-treatment with carbimazole for thyrotoxicosis: The Gateshead protocol | 2004 |
|
Dr Salman Razvi
Dr Elizabeth McIntyre
Dr Jolanta Weaver
| Low failure rate of fixed dose 400 MBq131I with pre-treatment with Carbimazole for thyrotoxicosis; The Gateshead protocol | 2004 |
|
